Stocks

Merck Insider Deluca Sells $788K Worth of Stock Amid Industry Woes

Guavy AI Editorial Team Published August 10, 2026

Instruments

MRK

On August 6, 2026, Richard Deluca, EVP & President of Merck Animal Health, sold 6,050 shares of Merck & Co Inc stock. The sale was disclosed in a SEC Filing filed on the same day.

The transaction price was $130.38 per share, totaling approximately $788,799. This sale brings Deluca's direct ownership to 155,487.07 shares.

Deluca has been selling Merck & Co Inc stock for over a year, with a total of 43,735 shares sold and no purchases made during that time. Insider selling activity at the company is predominantly bearish, with 17 insider sells in the past 12 months and no buys.

However, institutional investors tracked by GuruFocus present a different picture. Currently, 27 gurus hold Merck & Co Inc shares, with 10 adding to their positions and 14 trimming their holdings in recent quarters.

Merck Insider Deluca Sells $788K Worth of Stock Amid Industry Woes

IBM Re-Enters Canadian Bond Market with $2.75 Billion Deal

S7 Airlines Suffers Second Boeing 737 Runway Overrun in Six Weeks

Boeing Lands $75M Contract for JDAM LR Production